Novozymes A/S
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NVZMF research report →
About the company
Novozymes A/S, a Danish enterprise established in 1925 and headquartered in Bagsvaerd, is a leading provider of biological solutions, specializing in the production and global distribution of industrial enzymes, microorganisms, and probiotics. Its extensive reach spans across Europe, the Middle East, Africa, North America, Asia Pacific, and Latin America. The company's diverse portfolio caters to a wide array of sectors, including the food and beverage industry with innovations for baking, beverages, dairy, starch processing, and protein applications.
- CEO
- Ester Baiget
- IPO
- 2010
- Employees
- 10,582
- HQ
- Bagsvaerd, DK
Price Chart
- Market Cap
- $30.26B
- P/E
- 43.23
- P/S
- 6.33
- P/B
- 2.44
- EV/EBITDA
- 19.70
- Div Yield
- 1.52%
- Gross Margin
- 54.33%
- Op Margin
- 20.85%
- Net Margin
- 14.21%
- ROE
- 5.52%
- ROIC
- 4.44%
- Revenue
- $4.16B · 8.53%
- Net Income
- $583.60M · 90.98%
- EPS
- $1.25 · 86.57%
- Op Income
- $882.60M
- FCF YoY
- 13.73%
- 52W High
- $71.72
- 52W Low
- $52.10
- 50D MA
- $59.49
- 200D MA
- $60.43
- Beta
- 0.62
- Avg Volume
- 1.51K
Get TickerSpark's AI analysis on NVZMF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our NVZMF coverage
Recent articles, reports, and earnings notes.
No research on NVZMF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NVZMF report →Similar companies
Peers in the same neighborhood.